157 related articles for article (PubMed ID: 37675526)
1. [The efficacy and safety of standardized dust mite allergen subcutaneous immunotherapy in children with allergic rhinitis during treatment].
Yuan X; Xie SB; Zhang H; Zhang JY; Wang FJ; Liu YZ; Meng L; Zhong W; Jiang WH; Xie ZH
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2023 Sep; 58(9):878-884. PubMed ID: 37675526
[No Abstract] [Full Text] [Related]
2. [Efficacy comparison and safety analysis of subcutaneous specific immunotherapy with standardized house dust mite allergen in patients with single and multiple allergic rhinitis].
Huang HH; Xu C; Liu L; Chai RN
Zhonghua Yu Fang Yi Xue Za Zhi; 2022 Jun; 56(6):774-783. PubMed ID: 35785859
[No Abstract] [Full Text] [Related]
3. Long-Term Efficacy and Safety of Subcutaneous Immunotherapy in Monosensitized and Polysensitized Children With Allergic Rhinitis.
Yuan X; Xie S; Zhang H; Zhang J; Fan R; Jiang W; Xie Z
Otolaryngol Head Neck Surg; 2024 Mar; 170(3):919-927. PubMed ID: 38104318
[TBL] [Abstract][Full Text] [Related]
4. Intra-cervical lymphatic immunotherapy for dust mite-induced allergic rhinoconjunctivitis in children: a 3-year prospective randomized controlled trial.
Wang Q; Wang K; Qin Y; Huang W; Li Y; Yu Q; Xiong Y; Guo Y; Zheng R; Tang J
Front Immunol; 2023; 14():1144813. PubMed ID: 37593733
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of subcutaneous house dust mite immunotherapy in patients with moderate to severe allergic rhinitis.
Valero A; Ibáñez-Echevarría E; Vidal C; Raducan I; Castelló Carrascosa JV; Sánchez-López J
Immunotherapy; 2022 Jun; 14(9):683-694. PubMed ID: 35465692
[TBL] [Abstract][Full Text] [Related]
6. [A randomized controlled study on the long-term efficacy of intra-cervical lymphatic immunotherapy for adult allergic rhinitis].
Wang K; Qin Y; Wang QX; Huang WJ; Yu QQ; Li Y; Xiong Y; Guo YW; Tang J
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2023 Sep; 58(9):871-877. PubMed ID: 37675525
[No Abstract] [Full Text] [Related]
7. [Observation and analysis of systemic reactions to house dust mite subcutaneous immunotherapy in 362 patients with allergic rhinitis].
Xue JR; Ma J; Qiu CY; Hu ZB; Jiang X; Pan M; Lu MP; Cheng L
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2020 May; 55(5):445-451. PubMed ID: 32842357
[No Abstract] [Full Text] [Related]
8. [The efficacy of sublingual specific immunotherapy in children with allergic rhinitis].
Li P; Fa M; Huang ZH; Xie LS; Xu Y; Chen WB; Zhang JY; Zhang XR; Zhu Z; Li Q
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 Apr; 30(7):546-551. PubMed ID: 29871066
[No Abstract] [Full Text] [Related]
9. Effectiveness and adverse reactions to subcutaneous immunotherapy in children with allergic rhinitis/asthma.
Duman Senol H; Topyildiz E; Ekici B; Gulen F; Demir E
Int J Pediatr Otorhinolaryngol; 2022 Nov; 162():111292. PubMed ID: 36007303
[TBL] [Abstract][Full Text] [Related]
10. Does skin prick test response intensity predict symptom severity and efficacy of subcutaneous immunotherapy in allergic rhinitis?
Yuan X; Xie S; Meng L; Zhong W; Zhang H; Wang F; Fan R; Jiang W; Xie Z
Eur Arch Otorhinolaryngol; 2024 Feb; 281(2):767-774. PubMed ID: 37715808
[TBL] [Abstract][Full Text] [Related]
11. An evidence-based analysis of house dust mite allergen immunotherapy: a call for more rigorous clinical studies.
Calderon MA; Casale TB; Nelson HS; Demoly P
J Allergy Clin Immunol; 2013 Dec; 132(6):1322-36. PubMed ID: 24139829
[TBL] [Abstract][Full Text] [Related]
12. Salivary Immunoglobulin A, E, and G4 Levels Specific to Dermatophagoides pteronyssinus in Allergic Rhinitis Patients Treated With Subcutaneous Immunotherapy.
Liu Y; Xing Z; Wang J; Geng C
Am J Rhinol Allergy; 2018 Nov; 32(6):458-464. PubMed ID: 30124065
[TBL] [Abstract][Full Text] [Related]
13. Sublingual immunotherapy in children with allergic rhinoconjunctivitis mono-sensitized to house-dust-mites: a double-blind-placebo-controlled randomised trial.
Aydogan M; Eifan AO; Keles S; Akkoc T; Nursoy MA; Bahceciler NN; Barlan IB
Respir Med; 2013 Sep; 107(9):1322-9. PubMed ID: 23886432
[TBL] [Abstract][Full Text] [Related]
14. Semi-depot house-dust mite allergen extract for Chinese with allergic rhinitis and asthma.
Li X; Wang X; Lin X; Xu G; Tao Z; Jiang W; Cheng L; Guo Y; Lai H; Shen K
Am J Rhinol Allergy; 2016 May; 30(3):201-8. PubMed ID: 27216351
[TBL] [Abstract][Full Text] [Related]
15. [Long-term efficacy of house dust mite subcutaneous immunotherapy in allergic rhinitis patients].
Lou HF; Huang YR; Wang CS; Wang XD; Zhao Y; Cao FF; Zhang L
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 Nov; 32(21):1627-1631. PubMed ID: 30400685
[No Abstract] [Full Text] [Related]
16. [Comparison study of subcutaneous immunotherapy and sublingual immunotherapy in patients with allergic rhinitis].
You SH; Qin XY; Xu C; Qiu X; Luan ZL; Jia HX; Wang HT
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 May; 30(9):689-693. PubMed ID: 29771014
[No Abstract] [Full Text] [Related]
17. SQ house dust mite sublingually administered immunotherapy tablet (ALK) improves allergic rhinitis in patients with house dust mite allergic asthma and rhinitis symptoms.
Mosbech H; Canonica GW; Backer V; de Blay F; Klimek L; Broge L; Ljørring C
Ann Allergy Asthma Immunol; 2015 Feb; 114(2):134-40. PubMed ID: 25624131
[TBL] [Abstract][Full Text] [Related]
18. Safety of semi-depot house dust mite allergen extract in children and adolescents with allergic rhinitis and asthma.
Xiang L; Liu F; Zhi L; Jiang W; Liu C; Xie H; Zhou X; Sun Y; Zheng Y; Zhu R; Tao Z; Xia W; Lai H; Wei Q; Cheng L; Tang Y; Xu R; Huang H; Zhou Q; Chang P
Immunotherapy; 2021 Feb; 13(3):227-239. PubMed ID: 33317341
[No Abstract] [Full Text] [Related]
19. Single-allergen sublingual immunotherapy versus multi-allergen subcutaneous immunotherapy for children with allergic rhinitis.
Wang ZX; Shi H
J Huazhong Univ Sci Technolog Med Sci; 2017 Jun; 37(3):407-411. PubMed ID: 28585143
[TBL] [Abstract][Full Text] [Related]
20. Safety Profile and Issues of Subcutaneous Immunotherapy in the Treatment of Children with Allergic Rhinitis.
Endaryanto A; Nugraha RA
Cells; 2022 May; 11(9):. PubMed ID: 35563890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
